Rapamycin inhibits activation of ryanodine receptors from skeletal muscle by the fatty acyl CoA-acyl CoA binding protein complex

Rosella Fulceri, Roberta Giunti, Jens Knudsen, Rosanna Leuzzi, Tamas Kardon, Angelo Benedetti

Research output: Contribution to journalArticle

7 Citations (Scopus)


We previously showed that the fatty acyl CoA ester palmitoyl CoA (PCoA) complexed with a molar excess of its cytosolic binding protein (ACBP) causes a discrete Ca2+ efflux or allows Ca2+ release by suboptimal caffeine concentrations, in the Ca2+-preloaded terminal cisternae fraction (TC) from rabbit skeletal muscle, by activating ryanodine receptor Ca2+ release channels (RyRC). We show here that both effects were abolished by pretreating TC with the FKBP12 ligand rapamycin (20 μM). Moreover, rapamycin reversed the Ca2+ release induced by combined treatment with 3 mM caffeine and the PCoA-ACBP complex. Rapamycin also reduced the Ca2+-releasing activity by PCoA alone. Under the above experimental conditions, rapamycin removed FKBP12 from the TC membranes, as revealed by Western blot analysis. We conclude that FKBP12 associated with RyRC in the TC membrane participates in the activation of the Ca2+ channel by fatty acyl CoA esters.

Original languageEnglish
Pages (from-to)409-412
Number of pages4
JournalBiochemical and biophysical research communications
Issue number2
Publication statusPublished - Oct 22 1999


ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this